Navigation Links
China’s AIDS vaccine-successfully finishes first phas

According to the government health officials, initial clinical trials show that China’s first AIDS vaccine is safe and probably effective//.

"Forty-nine healthy people who received the injections showed no severe adverse reactions after 180 days, proving the vaccine was safe," said Zhang Wei, head of the pharmaceutical registration department of the State Food and Drug Administration (SFDA).

"The recipients appeared immune to the HIV-1 virus 15 days after the injection, indicating the vaccine worked well in stimulating the body's immunity," he told a press conference in Beijing.

The first phase of clinical trials, which focused on the vaccine’s safety comes to an end with these results.

Sang Guowei, director of the National Institute for the Control of Pharmaceutical and Biological Products, said that the second-round tests will require at least 300 volunteers and the third phase at least 500.

According to Chen Jie, deputy director of the Guangxi Regional Center for Disease Control and Prevention, participation of high-risk groups will be involved in the later trials.

The first phase of clinical trials began in March 2005 in Nanning, which is the capital of the Guangxi Zhuang Autonomous Region. 33 men and 16 women aged between 18 and 50 years, volunteered for this trial. They were divided into 8 groups, of which, 6 groups were given a single AIDS vaccine and the others were injected with a combined AIDS vaccine. This was reported by the Guangxi center for disease control.

”The HIV-1 specific cells injected into the recipients were the DNA fragments of the virus that don't cause infection,” Sang said.

”Some recipients' cells and body fluids in the combined group appeared immune to the HIV-1 virus.”

Kong Wei, leader of the research team and a professor at Jilin University said, ”A total 344 blood samples were taken from the volunteers, with each one donating five to 10 samples.”

The volunteers exhibited no serious ill effects even after 180 days of observation.

According to the SFDA officials, the scientists will continue analysis of the results of the first phase, before SFDA approves the beginning of the second phase, after a rigorous assessment.

Assessment of safety and immunity comprises the second phase while the third is concerned with how the vaccine will provide protection to the high-risk groups.

According to the 2005 Update on the HIV/AIDS Epidemic and Response in China, 6,50,000 people in this country are living with HIV/AIDS while 75,000 with clinical AIDS.

Scientists and other experts concerned with the drastic increase in the spread of the disease, urged the State Council, China's cabinet, to raise funding for and encourage innovation and cooperation in research.

International funding worth 123.2 million U.S. dollars was given to China recently by the Global Fund to Fight HIV/AIDS, Tuberculosis and Malria.
'"/>




Related medicine news :

1. Mystery over bird flu infection to Ms. Zhou – China’s 7th bird flu victm
2. Lower Birth Rate and Fewer Girls under China’s one Child Polic
3. Infant receives first bloodless liver transplant
4. Oracle Corp. to help build worlds first "Digital Hospital"
5. FDA approves first pocket-sized EKG machine
6. Valerian was first epilepsy drug
7. New device for ailing heart fitted into first patient
8. Canada helps in giving birth to world first baby from frozen egg
9. SNUPPY – Woo Suk Hwang reveals World’s first dog cloe
10. Successful creation of human embryos from a single parent for the first time
11. A first for India - IVF baby born of surrogacy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... San Antonio, TX (PRWEB) , ... May 22, 2017 , ... ... It starts with a body squatted, stretched, jumped, toned and shaped through fitness programs. ... And it is, of course, finished off with an irresistible, radiant smile. CDA ...
(Date:5/21/2017)... ID (PRWEB) , ... May 20, 2017 , ... ... financial integration systems between ABC Financial Services and financial systems. , ... link or exported files that are electronically processed through GetLinked into their club’s ...
(Date:5/21/2017)... ... ... For more than 20 years United Cutlery has been distinguished by unique and ... to fantasy. United Cutlery has always been “Stronger. Sharper” than the competition and it ... a range of weapons and tools built for battle, the M48 line by United ...
(Date:5/19/2017)... ... May 19, 2017 , ... ... an upcoming episode of Innovations with Ed Begley, Jr., airing fourth quarter 2017 ... distributor of a clean, organic dietary supplement made from naturally occurring ingredients. Innovations ...
(Date:5/19/2017)... , ... May 19, 2017 , ... ... 2017 class of Beckman Young Investigators: , Victor Acosta, Ph.D. - University of ... University, Dan Fu, Ph.D. - University of Washington, Erik Grumstrup, Ph.D. - Montana ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... May 4, 2017  A new tight-tolerance microextrusion ... other highly-engineered materials, is being launched by Natvar, ... been developed in recent years to service a ... surgical applications. More expensive materials such as glass ... tubing due to their ability to consistently hold ...
(Date:5/3/2017)... , May 3, 2017  Kalorama Information notes ... nine percent next year and this is projected ... hematopoietic stem cell (HSCT) or bone marrow transplants ... technologies are well-suited for this task. This according ... publisher Kalorama Information. The various PCR-based methodologies, Sanger ...
(Date:5/2/2017)... and LONDON , May ... market intelligence, MarketResearch.com is pleased to announce a business ... that allows for the marketing and distribution of ... through the MarketResearch.com website. The new relationship ... complete product descriptions and tables of contents from research ...
Breaking Medicine Technology: